FeesSafety
Pluang+

First Hawaiian and TriCo shareholders approve merger, aiming to create a leading regional bank by late 2026.

Company Fundamentals
30 Oct 2026, 06:00 WIB
Na
View Source
Bullish
First Hawaiian and TriCo shareholders approve merger, aiming to create a leading regional bank by late 2026.

First Hawaiian, Inc. and TriCo Bancshares have received shareholder approval for First Hawaiian's acquisition of TriCo, pending customary closing conditions. This merger aims to combine their banking services and expand their capacity to serve customers in Hawaii, Guam, Saipan, and California. The transaction is expected to close later in 2026, creating a stronger regional bank with enhanced products and lending capabilities. Both companies emphasize careful integration planning and long-term value creation for shareholders.

First Hawaiian, Inc. and TriCo Bancshares' acquisition news comes with this market context from Pluang. Of 142 Financials-sector US stocks priced on Pluang, 105 rose and 37 fell today. OWL traded at USD 10.26 with a 6.10% gain and 100% buy orders, as of Oct 30, 2026 05:31 WIB.

More News

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

Market News
Neutral
12 minutes ago
SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...

Company Fundamentals
Bullish
1 hour ago
All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...

Market News
Bullish
5 hours ago
New AI-assisted cyberattack targets Bitcoin mining infrastructure during price drop

New AI-assisted cyberattack targets Bitcoin mining infrastructure during price drop

A new cyberattack using AI assistance has targeted Bitcoin mining infrastructure amid a recent price decline. Luxor's CEO revealed the sophisticated nature of the attack and announced plans to review the incident and apologize to affected customers. ...

Market News
Bearish
5 hours ago
Meteora launches DLMM Pro beta on Solana, enabling customizable liquidity and NFT-transferable positions

Meteora launches DLMM Pro beta on Solana, enabling customizable liquidity and NFT-transferable positions

Meteora AG has introduced DLMM Pro in beta on the Solana blockchain, offering token creators new tools to customize liquidity and fees. The platform integrates Meteora’s Dynamic Liquidity Market Maker, DAMM V2, and Dynamic Bonding Curve technologies,...

Protocol Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App